Nature Cell (007390) has 3 disclosed insider purchases and 7 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩3.7B ($2.5M) in reported transaction value. The earliest filing StockDrifts holds for Nature Cell is dated 2024-07-16; the most recent is 2026-03-27. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -7.92%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | BUY | Market Buy | 라정찬 Rajeongchan | CEO | 55.9K | ₩18,280 | +14.6% | ₩1.0B ($709K) |
| 2026-03-26 | BUY | Market Buy | 라정찬 Rajeongchan | CEO | 58.7K | ₩17,100 | +22.5% | ₩1.0B ($697K) |
| 2026-03-20 | BUY | Market Buy | 라정찬 Rajeongchan | CEO | 54.7K | - | - | - |
| 2025-12-22 | SELL | Market Sell | 변대중 Byeon Dae-jung | Hospital Director | -10.0K | ₩22,400 | -2.9% | ₩224M ($156K) |
| 2025-09-22 | SELL | Market Sell | 변대중 Byeon Dae-jung | Hospital Director | -9.6K | ₩20,650 | -11.6% | ₩198M ($138K) |
| 2025-04-30 | BUY | 주식매수선택권 | 박상철 Park Sang-cheol | Internal director | 3.0K | ₩26,200 | -12.0% | ₩79M ($55K) |
| 2025-03-25 | SELL | Market Sell | 라정찬 Rajeongchan | (Labor Director) | -12.0K | ₩28,850 | +20.1% | ₩346M ($240K) |
| 2025-03-24 | SELL | Market Sell | 라정찬 Rajeongchan | (Labor Director) | -12.0K | ₩22,200 | -3.8% | ₩266M ($185K) |
| 2025-03-21 | SELL | Market Sell | 라정찬 Rajeongchan | (Labor Director) | -12.0K | ₩17,110 | -34.7% | ₩205M ($143K) |
| 2025-03-20 | SELL | Market Sell | 라정찬 Rajeongchan | (Labor Director) | -12.0K | ₩16,490 | -39.8% | ₩198M ($137K) |
| 2025-03-19 | SELL | Market Sell | 라정찬 Rajeongchan | (Labor Director) | -12.0K | ₩16,990 | -35.7% | ₩204M ($142K) |
| 2024-07-16 | SELL | 대물변제 | 라정찬 Rajeongchan | (Labor Director) | -750.0K | ₩10,250 | -124.9% | ₩7.7B ($5.3M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Nature Cell. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.